Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Kalaris Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 84 | 1 | 80 | −3 |
| Shares | 26.4M | 112.5K | 25.6M | −769.2K (−2.9%) |
| Value | $521.8M | $2.22M | $640.3M | +$120.7M (+23.2%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Kalaris Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GMT Capital Corp | 476,488 | $11.9M | 1.05% |
| Wellington Management Group LLP | 267,996 | $6.72M | 0.00% |
| E. Ohman J:or Asset Management AB | 72,400 | $1.81M | 0.06% |
| Endurant Capital Management LP | 44,430 | $1.11M | 0.34% |
| Susquehanna Fundamental Investments, LLC | 23,818 | $597.0K | 0.01% |
| Jump Financial, LLC | 15,227 | $381.0K | 0.03% |
| Arizona State Retirement System | 9,754 | $244.0K | 0.00% |
| Quantbot Technologies LP | 5,047 | $126.0K | 0.01% |
| Dark Forest Capital Management LP | 4,881 | $122.0K | 0.04% |
| Amundi | 1,470 | $37.0K | 0.00% |
| Harbour Investments, Inc. | 15 | $0 | 0.00% |
| Ellevest, Inc. | 9 | $0 | 0.00% |
Sold out (15)
Institutions that held Kalaris Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| EcoR1 Capital, LLC | 447,012 | $8.82M |
| Millennium Management LLC | 87,195 | $1.72M |
| HRT Financial LP | 80,181 | $1.58M |
| Twin Focus Capital Partners, LLC | 59,359 | $1.17M |
| Tudor Investment Corp Et Al | 35,480 | $700.0K |
| Voloridge Investment Management, LLC | 28,504 | $563.0K |
| Renaissance Technologies LLC | 28,000 | $553.0K |
| Squarepoint Ops LLC | 21,848 | $431.0K |
| Jane Street Group, LLC | 18,986 | $375.0K |
| Cna Financial Corp | 13,405 | $265.0K |
| Benjamin F. Edwards & Company, Inc. | 1,554 | $31.0K |
| Advisory Services Network, LLC | 139 | $3.00K |
| TCI Wealth Advisors, Inc. | 87 | $2.00K |
| Point72 Hong Kong Ltd | 122 | $2.00K |
| Signaturefd, LLC | 38 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Kalaris Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 112,478 | $2.22M |